Search Results

New Clinical Medicine Study Results from University of Wollongong Described (Prevention of Pregnancy Complications Using a Multimodal Lifestyle, Screening, and Medical Model)

• Source: Women's Health Weekly. August 15, 2024, 3530

Record details

Prevention of Pregnancy Complications Using a Multimodal Lifestyle, Screening, and Medical Model.

• Authors : Parker J; School of Medicine, University of Wollongong, Wollongong 2522, Australia.; Hofstee P

• Source: Journal of clinical medicine [J Clin Med] 2024 Jul 25; Vol. 13 (15). Date of Electronic Publication: 2024 Jul 25.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383

Record details

PREVENTIVE MEASURES OF HYPERTENSIVE SYNDROMES OF PREGNANCY IN PRIMARY CARE/MEDIDAS PREVENTIVAS DAS SÍNDROMES HIPERTENSIVAS DA GRAVIDEZ NA ATENÇÃO PRIMÁRIA/MEDIDAS PREVENTIVAS DE LOS SÍNDROMES HIPERTENSIVOS DEL EMBARAZO EN LA ATENCIÓNPRIMARIA

• Authors : de Moráis Chaves Thuler, Andréa Cristina¹; Wall, Marilene Loewen²; Benedet, Deisi Cristine Forlin²

Subjects: Prevention of pregnancy complications; Hypertension; Prenatal care

• Source: Words Without Borders: The Online Magazine for International Literature. Apr2018, Vol. 12 Issue 4, p1060-1071. 12p. 1 Diagram, 2 Charts.

Record details

New Clinical Medicine Study Results from University of Wollongong Described (Prevention of Pregnancy Complications Using a Multimodal Lifestyle, Screening, and Medical Model).

• Source: Women's Health Weekly; 8/16/2024, p365-365, 1p

Record details

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.

• Authors : Rodger, Marc A.; Hague, William M.; Kingdom, John

Subjects: DALTEPARIN (Drug); PREVENTION of pregnancy complications; GENETIC disorders

• Source: Lancet. 11/8/2014, Vol. 384 Issue 9955, p1673-1683. 11p. 1 Diagram, 2 Charts, 2 Graphs.

Record details

Prevention of Pregnancy Complications in Antiphospholipid Syndrome.

• Authors : Czwalinna A; amedes MVZ wagnerstibbe für Laboratoriumsmedizin, Hämostaseologie, Humangenetik und Mikrobiologie, Hannover, Germany.; Bergmann F

Subjects: Antiphospholipid Syndrome/Antiphospholipid Syndrome/Antiphospholipid Syndrome/*diagnosis ; Pregnancy Complications/Pregnancy Complications/Pregnancy Complications/*prevention & control; Antiphospholipid Syndrome/Antiphospholipid Syndrome/Antiphospholipid Syndrome/physiopathology

• Source: Hamostaseologie [Hamostaseologie] 2020 Jun; Vol. 40 (2), pp. 174-183. Date of Electronic Publication: 2020 May 26.Publisher: Thieme Country of Publication: Germany NLM ID: 8204531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-5761

Record details

Patent Issued for Prevention Of Pregnancy Complications By Noble Gas Administration (USPTO 10,485,825)

• Source: Women's Health Weekly. December 12, 2019, 916

Record details

Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program.

• Authors : Romero, Lisa (AUTHOR); Koonin, Lisa M. (AUTHOR); Zapata, Lauren B. (AUTHOR)

Subjects: CONTRACEPTION; ZIKA virus infections; ADVERSE health care eventsPUERTO Rico

• Source: American Journal of Public Health. 2018 Suppl 3, Vol. 108, pS227-S230. 4p.

Record details

MOTHERS IN PERIL.

• Authors : NUILA, RICARDO

Subjects: MATERNAL mortality; ABORTION prevention; RIGHT of privacy & medical records

• Source: Texas Monthly. May2018, p98-174. 17p.

Record details

'Prevention of Pregnancy Complications by Noble Gas Administration' in Patent Application Approval Process (USPTO 20180055876)

• Source: Women's Health Weekly. March 22, 2018, 7787

Record details